Dow Up 0.08% Nasdaq Down 0.30%

Arrowhead Research Corp. (ARWR)

-NasdaqGS
15.25 Down 0.46(2.93%) Sep 19, 4:00PM EDT
|After Hours : 15.30 Up 0.05 (0.33%) Sep 19, 5:10PM EDT
Prev Close:15.71
Open:15.80
Bid:15.05 x 100
Ask:15.43 x 300
1y Target Est:33.50
Beta:2.95
Next Earnings Date:N/A
Day's Range:15.03 - 15.85
52wk Range:4.51 - 27.63
Volume:3,625,709
Avg Vol (3m):3,209,240
Market Cap:806.85M
P/E (ttm):N/A
EPS (ttm):-1.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARWRDown 2.93%806.85M
APNT 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4,749.65
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-1.05
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-1.98

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. The company’s product candidate comprise ARC-520, an RNAi-based therapeutic that has completed a Phase 1 clinical trial for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback